Results 191 to 200 of about 69,829 (275)

The impact of intravenous immunoglobulin therapy on resource utilization associated with viral respiratory tract infections. [PDF]

Front Immunol
Azar A, Runken MC, Moughames E, Howden R, Oh J, Blanchette CM.   +5 more
europepmc   +1 more source

Daily interferon plus ribavirin for HCV-related compensated cirrhosis: Preliminary results

, 2000
Laura Fastame, D. Mura, Gavino Pisanu, Rita Mele, Maria Pina Dore, G. Realdi   +5 more
openalex   +1 more source

Identification and Characterization of Antiviral Activity of Synthetic Compounds Against Mayaro Virus. [PDF]

Pharmaceuticals (Basel)
Andreolla AP, Koishi AC, Borges AA, Oliveira LA, Oliveira VG, Lima NM, Ávila EP, de Castro PP, Amarante GW, de Almeida MV, Bordignon J, Duarte Dos Santos CN.   +11 more
europepmc   +1 more source

Oxidative stress and IFN + ribavirin combination therapy in patients with chronic hepatitis C

, 2000
Filomena Morisco, Veronica Verde, Vincenzo Fogliano, Alberto Ritieni, P. Iasevoli, Concetta Tuccillo, Giuseppina De Luise, N. Caporaso   +7 more
openalex   +1 more source

Directly acting antivirals improve insulin resistance in nondiabetic patients with hepatitis C: a systematic review and meta-analysis. [PDF]

Ann Med Surg (Lond)
Lamichhane P, Makhlouf SSK, Saleem K, Senliya D, Wajid A, Khanal K, Agrawal A.   +6 more
europepmc   +1 more source

Adaptive Design for Phase II/III Platform Trial of Lassa Fever Therapeutics. [PDF]

Emerg Infect Dis
Bourner J, Vaillant M, Abdel Salam AP, Jaspard M, Fritzell C, Jacob ST, Fletcher TE, Ramharter M, Ajayi N, Okogbenin S, Erameh C, Grant D, Samuels R, Ayodeji OO, Sprecher A, Gonçalves BP, Edwards T, Olliaro P, WALC Work Package 2 Working Group.   +18 more
europepmc   +1 more source

Comparative Pharmacovigilance Analysis of Approved and Repurposed Antivirals for COVID-19: Insights from EudraVigilance Data. [PDF]

Biomedicines
Negru PA, Tit DM, Radu AF, Bungau G, Corb Aron RA, Marin RC.   +5 more
europepmc   +1 more source

Safety of ribavirin with mechanical ventilation

The Pediatric Infectious Disease Journal, 1990
openaire   +4 more sources

The commercial PRRSV attenuated vaccine can be a potentially effective live trivalent vaccine vector. [PDF]

Appl Microbiol Biotechnol
Li Y, Wang Y, Pei X, Wu Y, Chen S, Weng H, Jing Y, Ma Z, Li Z, Zheng Z, Feng Y, Xu L, Guo X, Liu X, Zhang J, Zheng H, Xiao S.   +16 more
europepmc   +1 more source

Hepatitis E vaccination: the promise of prevention. [PDF]

Proc (Bayl Univ Med Cent)
Gonzalez SA.
europepmc   +1 more source